Medical specialists from Austria tagged as investigators in clinical trials studying Blastomycosis

Total 3 results

Günter Weiss, Prof. Dr.
Seen in:
- Innsbruck, Medical University Innsbruck
Trials:
- NCT03059992 (Principal Investigator)
Conditions:
Robert Krause, PD Dr. med.
Seen in:
- Graz, Medical University of Graz Department of Internal Medicine, Department of Pulmology, Section for Infectious Disease and Tropical Medicine
Trials:
- NCT03059992 (Principal Investigator)
Conditions:
Stephan Eschertzhuber, Prof. Dr.
Seen in:
- Innsbruck, Medical University Innsbruck
Trials:
- NCT03059992 (Sub-Investigator)
Conditions:

Clinical Trials on Blastomycosis

University of Manitoba
Pfizer

Terminated

Amphotericin-B and Voriconazole for Pulmonary Blastomycosis (BLASTO)

Blastomycosis

Canada
National Cancer Institute (NCI)

Completed

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection

Blastomycosis

United States
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Completed

Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis

Histoplasmosis | Sporotrichosis | Blastomycosis
Janssen, LP

Completed

A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis

HIV Infections | Histoplasmosis | Blastomycosis

United States
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Completed

Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis

Histoplasmosis | Sporotrichosis | Blastomycosis
Janssen Pharmaceutical K.K.

Completed

A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection

Mycoses | Candidiasis | Neutropenia | Aspergillosis | Cryptococcosis | Histoplasmosis | Blastomycosis

Japan
Scynexis, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)

Coccidioidomycosis | Invasive Pulmonary Aspergillosis | Allergic Bronchopulmonary Aspergillosis | Histoplasmosis | Chronic Pulmonary Aspergillosis | Blastomycosis | Invasive Candidiasis | Recurrent Vulvovaginal Candidiasis | Mucocutaneous Candidiasis | Other Emerging Fungi

United States, Spain, United Kingdom, Austria, Pakistan, South Africa, Germany, Netherlands

Medical specialists from Austria tagged as investigators in clinical trials studying Blastomycosis

Clinical Trials on Blastomycosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations